Tech News
← Home  ·  All topics

World Health Organization

4 GoKawiil briefs on this topic · RSS for world health organization

Mosqitter expands AI-based mosquito surveillance network across 5,000 traps

Pennsylvania-based startup Mosqitter, which makes chemical-free mosquito traps that mimic human heat, scent and breath, says it now has more than 5,000 devices deployed across five continents, up from roughly 250 in 2022. CEO Anastasiia Romanova told TechCrunch the company is turning these traps into an AI-powered monitoring network designed to identify mosquito species, track population changes and provide earlier warnings of disease risk.

Siberian lab plague death raises transparency concerns, not outbreak risk

A 28-year-old researcher died at Russia's Anti-Plague Research Institute in Irkutsk, with unverified reports suggesting around 200 people may have been quarantined after possible exposure. Russian health officials initially said there was no emergency and attributed the death to pneumonia of unknown origin, only confirming five days later that the researcher had been vaccinated against plague and that extensive testing found no dangerous pathogens in her or others.

CDC, WHO say plague risk low after Russian lab researcher's death

A researcher at Russia's Irkutsk Anti-Plague Institute died of unexplained severe pneumonia after reportedly breaking a test tube, prompting quarantine of the treating hospital and isolation of her coworkers. The CDC said the case's circumstances remain unconfirmed and there's no sign of broader threat to the US, while the WHO said it has contacted Russian authorities and assesses public health risk as very low.

CEPI redirects $100M as DRC Ebola outbreak becomes deadliest ever recorded

CEPI, a nonprofit focused on epidemic preparedness, says the Bundibugyo Ebola outbreak in the Democratic Republic of Congo has infected more than 7,000 people since May, with roughly half dying, per WHO-compiled government data. The group shifted $100 million to fund vaccine development, including doses from the Serum Institute of India based on Oxford's ChAdOx1 BDBV candidate, alongside a Moderna candidate, both now in safety trials with efficacy trials expected this month.